Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ratain

Showing results (1-10 of 225) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Insights into the pharmacokinetics and pharmacodynamics of irinotecanM J Ratain
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Drug combinations: dangerous liaisons or great expectations?M J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Dose reduction of etoposide in jaundiced patientsM J Ratain
Seminars in Oncology|August 1, 1992
Therapeutic relevance of pharmacokinetics and pharmacodynamicsM J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit?M J Ratain
Clinical Pharmacology and Therapeutics|March 7, 2007
Personalized medicine: building the GPS to take us thereM J Ratain
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Update on pharmacogenetics in cancer chemotherapyF Innocenti, M J Ratain
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacodynamics and long-term toxicity of etoposideK Kobayashi, M J Ratain
Investigational New Drugs|June 8, 2001
Body surface area as a determinant of pharmacokinetics and drug dosingM Sawyer, M J Ratain
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase I study of escalating does of carboplatinR Mick, M J Ratain
Pageof 23

Showing results (1-10 of 225) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Insights into the pharmacokinetics and pharmacodynamics of irinotecanM J Ratain
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Drug combinations: dangerous liaisons or great expectations?M J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Dose reduction of etoposide in jaundiced patientsM J Ratain
Seminars in Oncology|August 1, 1992
Therapeutic relevance of pharmacokinetics and pharmacodynamicsM J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit?M J Ratain
Clinical Pharmacology and Therapeutics|March 7, 2007
Personalized medicine: building the GPS to take us thereM J Ratain
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Update on pharmacogenetics in cancer chemotherapyF Innocenti, M J Ratain
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacodynamics and long-term toxicity of etoposideK Kobayashi, M J Ratain
Investigational New Drugs|June 8, 2001
Body surface area as a determinant of pharmacokinetics and drug dosingM Sawyer, M J Ratain
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase I study of escalating does of carboplatinR Mick, M J Ratain
Pageof 23